HBC(SH:603077)2024-04-19 08:52Financial Performance - The company's operating revenue for Q1 2024 was CNY 1,999,261,196.40, representing a decrease of 16.51% compared to the same period last year[4] - The net profit attributable to shareholders of the listed company was CNY 29,792,564.09, down 92.49% year-on-year[4] - Basic earnings per share decreased by 92.09% to CNY 0.0036[4] - Operating profit for Q1 2024 was CNY 43,612,198.85, down from CNY 477,206,214.04 in Q1 2023[18] - Net profit attributable to shareholders for Q1 2024 was CNY 29,792,564.09, compared to CNY 396,561,190.75 in Q1 2023, reflecting a significant decline[19] - The company recorded a total comprehensive income of CNY 28,631,801.49 for Q1 2024, compared to CNY 370,228,317.28 in Q1 2023[19] - The company reported a decrease in total costs for Q1 2024 to CNY 1,944,326,999.84, compared to CNY 1,917,401,447.52 in Q1 2023[17] Cash Flow - The net cash flow from operating activities was negative at CNY -433,373,338.57, a decline of 224.74% compared to the previous year[4] - Cash flow from operating activities for Q1 2024 showed a net outflow of CNY -433,373,338.57, compared to a net inflow of CNY 347,430,102.23 in Q1 2023[20] - Cash outflow from investment activities totaled 244,612,808.67, compared to 167,714,824.15 in the previous period[21] - Net cash flow from investment activities was -239,701,777.70, a decrease from -165,179,305.15 year-over-year[21] - Cash inflow from financing activities amounted to 1,531,191,082.47, significantly higher than 220,086,289.50 in the prior period[21] - Cash outflow from financing activities totaled 1,111,827,029.55, compared to 412,483,553.80 previously[21] - Net cash flow from financing activities was 419,364,052.92, a recovery from -192,397,264.30 in the previous year[21] - The net increase in cash and cash equivalents was -253,784,803.09, compared to -23,240,242.97 in the prior period[21] - The ending balance of cash and cash equivalents was 2,651,047,038.99, down from 4,521,617,841.20 year-over-year[21] - The company reported a significant increase in cash received from borrowings, totaling 1,531,191,082.47 compared to 220,086,289.50 previously[21] Assets and Liabilities - Total assets at the end of the reporting period were CNY 25,639,014,575.53, an increase of 4.47% from the end of the previous year[5] - The total assets of the company as of March 31, 2024, were approximately ¥25.64 billion, an increase from ¥24.54 billion at the end of December 2023, reflecting a growth of about 4.4%[15] - Total liabilities increased to approximately ¥5.96 billion from ¥4.32 billion, marking a rise of about 38.0%[15] - The equity attributable to shareholders of the listed company was CNY 19,033,820,331.82, a decrease of 2.77% from the previous year[5] - The company’s total equity attributable to shareholders was CNY 19,033,820,331.82 as of Q1 2024, down from CNY 19,575,342,485.28 in the previous year[16] Shareholder Information - The number of ordinary shareholders at the end of the reporting period was 221,530[8] - The largest shareholder, Sichuan Hebang Investment Group Co., Ltd., held 22.24% of the shares, with 1,963,779,103 shares pledged[8] Projects and Investments - The company has completed the construction of two photovoltaic glass production lines and a 2GW photovoltaic module production line, but will pause further investment in the photovoltaic module project due to high industry inventory levels[11] - The N-type monocrystalline silicon wafer project has achieved a production capacity of 1.5-2GW, but the company will not increase investment in the short term due to rapid market price declines[11] - The company is nearing completion of the 1 million tons per year phosphate mine project, expected to commence production in 2024[12] - The company has initiated preparations for a 500,000 tons per year glyphosate project, with preliminary work completed and construction underway[12] - The company has submitted investment application materials to the relevant authorities for a project in Indonesia, which aims for a production capacity of 600,000 tons of sodium carbonate and ammonium chloride[12] Other Information - The company reported non-recurring gains and losses totaling CNY 1,707,779.73 for the period[6] - The company did not apply new accounting standards or interpretations starting in 2024[21] - Research and development expenses for Q1 2024 were CNY 8,346,347.48, slightly down from CNY 9,108,322.93 in Q1 2023[17]